The RHÖN-KLINIKUM AG and Siemens Medical Solutions signed a contract just over a year ago for the construction and operation of a particle therapy facility. With the permit approval process and application hearing now underway, the high-tech project is beginning to take shape. Construction is expected to begin in the summer of 2007.

Suppliers in the highly competitive and fragmented European virtual screening market face challenges such as limited scientific audience and the lack of common technology standards. Also, despite the high demand for software tools, companies need to develop and introduce the right kind of tools and solutions to broaden their customer base.

Philips Medical Systems NetForum Community website for MRI has proved so successful that the Company has now extended it to encompass CT users as well.

Ever-increasing workload and time constraints often make it difficult to meet with colleagues face-to-face, or to be fully engaged in professional organisations.

WebVMC, developer of the RemoteNurse™ telehealth system that enables 24 hour virtual medical care for remote disease management, has entered into an exclusive partnership with Home Telehealth Ltd., (HTL) one of the United Kingdom's leading providers of telehealth products and managed care services.

Siemens Medical Solutions today opened the doors to a new state-of-the-art research facility dedicated exclusively to the development of molecular imaging biomarkers, which will become in vivo diagnostic tools for identifying debilitating diseases such as cancer, and neurological diseases at their earliest stages.

Intel Corporation, in conjunction with the IDA Ireland (Industrial Development Agency) have started a research initiative based in Ireland to address the growing wave of ageing citizens in Europe and around the world, according to the recent news article from the Technology Research for Independent Living (TRIL) Centre.

Royal Philips Electronics (NYSE:PHG, AEX:PHI) has joined forces with AstraZeneca, Merck & Co., BG Medicine and Humana to form the High-Risk Plaque (HRP) Initiative to research and advance the understanding, recognition and management of high-risk plaque, the primary underlying cause of heart attacks.